Understanding Patients with Type 2 Diabetes Mellitus Using Oral Antidiabetic Drugs

  • Grace Y Irene Faculty of Medicine Universitas Padjadjaran
  • Kuswinarti Kuswinarti
  • Maya Kusumawati

Abstract

Uncontrolled hyperglycemia in people with diabetes mellitus can increase the risk of diabetes complications and comorbidities. This study aimed to determine the demographic, clinical, history, complications, and comorbid characteristics of diabetes. The study was conducted with a descriptive method and cross-sectional research design. Data were collected retrospectively using medical record data and using the Finite Population Correction formula with a sample of 115. The results showed the majority of patients were female (67.8%), aged ? 65 years (40.0%), residing in urban (87.6%), high school graduates (35.2%), and unemployed (63.6%). Patients generally have a normal BMI (45.9%) and have several variables that reach the target, namely fasting blood glucose (50.4%), triglycerides (55.3%), and creatinine (69.6%). Patients also had several variables that did not reach the target, namely postprandial 2 hour blood glucose (51.3%), blood pressure (65.8%), total cholesterol (55.6%), HDL cholesterol (54.5%), LDL cholesterol (80.0%), and urea (56.0%). Patients who use oral anti-diabetes generally have used it <5 years (76.3%) and used monotherapy (63.5%). Neuropathy (42.6%) and hypertension (85.9%) were the most common complications and comorbidities of diabetes in this study. Strict glycemic control is an important management for people with diabetes mellitus.   Keywords: oral antidiabetic drugs; diabetes mellitus; comorbid  

Downloads

Download data is not yet available.

References

David G. Gardner, MD M, Shoback D. Greenspan’s Basic & Clinical Endocrinology, Ninth Edition. China: Mc Graw Hill; 2011. 587 p.

Soelistijo SA, Novida H, Rudijanto A, Soewanda P, Suastika K, Manaf A, et al. Konsensus Pengolahan dan Pencegahan Diabetes Melitus Tipe 2 Di Indonesia 2015. Pengurus Besar Perkumpulan Endokrinologi Indonesia (PB PERKENI); 2015.

World Health Organization. Global Report on Diabetes. 2016;

IDF. IDF Diabetes Atlas. International Diabetes Federation. 2015. 1-163 p.

Cockram CS. The epidemiology of diabetes mellitus in the Asia-. 2000;6(1).

Badan Penelitian dan Pengembangan Kesehatan. Riset Kesehatan Dasar (RISKESDAS) 2013. Lap Nas 2013. 2013;1–384.

Tunceli K, Bradley CJ, Nerenz D, Williams LK, Pladevall M, Lafata JE. The impact of diabetes on employment and work productivity. Diabetes Care. 2005;28(11):2662–7.

Economic Costs of Diabetes in the U.S. in 2012. 2013;

Of D, Mellitus D. Diagnosis and Classi fi cation of Diabetes Mellitus. 2014;37(January):81–90.

Investigation O. Sex Differences in Risk Factors for Incident Type 2 Diabetes Mellitus. 2002;162.

Salpeter SR, Walsh JME, Ormiston TM, Greyber E, Buckley NS, Salpeter EE. Meta-analysis : effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. 2006;538–54.

Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, et al. Relationship of adiponectin to body fat distribution , insulin sensitivity and plasma lipoproteins : evidence for independent roles of age and sex. 2003;459–69.

Goal- IOFI, In S, Mellitus D. Guidelines for Improving the Care of the Older Person with Diabetes Mellitus. 2003;

Fletcher B, Gulanick M, Lamendola C. Risk factors for type 2 diabetes mellitus. J Cardiovasc Nurs. 2002;16(2):17–23.

Ralph A. Glucose Intolerance and Aging. 1981;4(4):493–501.

Mooradian AD, McLaughlin S, Boyer CC. Diabetes Care for Older Adults. Diabetes Care Older Adults. 1999;12:70–7.

Affairs M, Information C, Physicians E, Arbor A, Israel B, Medical D. Diabetes in Older Adults. 2012;35(10).

Guo X, Yuan L. A Nationwide Survey of Diabetes Education, Self-management and Glycaemic Control in Patients With Type 2 Diabetes in China. Chin Med J (Engl). 2012;

England TN. NUMB ER 18 PREVENTION OF TYPE 2 DIABETES MELLITUS BY CHANGES IN LIFESTYLE AMONG SUBJECTS WITH IMPAIRED GLUCOSE TOLERANCE. 2001;344(18):1343–50.

Natural R, Proctitis GH, Williams A, Kreel I. Physical activity and incidence of non-insulin-dependent diabetes mellitus in. 1990;774–8.

Mohan, V., Sandeep S., Deepa, R., Shah, B., Varghese C. Epidemiology of type 2 diabetes: Indian scenario. 2007.

Ketema EB, Kibret KT. Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control ; systematic review and. Arch Public Heal [Internet]. 2015;1–9. Available from: http://dx.doi.org/10.1186/s13690-015-0088-6

Ambady Ramachamdran M, Matthew C. Riddle M, Conrad Kabali Ph. Relationship Between A1C and Fasting Plasma Glucose in Dysglycemia or Type 2 Diabetes. 2012;0–4.

Vlckova V, Cornelius V, Kasliwal R, Wilton L, Shakir SAW. Hypoglycaemia with Oral Antidiabetic Drugs Results from Prescription-Event Monitoring Cohorts of. 2009;32(5):409–18.

Third T, Health N, Survey NE. Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults. 1998;21(4):518–24.

Prospective UK, Study D. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes ( UKPDS 33 ). 1998;352(Ukpds 33):837–53.

Jelinek HF, Osman WM, Khandoker AH, Khalaf K, Lee S, Almahmeed W, et al. Clinical profiles , comorbidities and complications of type 2 diabetes mellitus in patients from United Arab Emirates. 2017;1–10.

Paolisso G, Barbagallo M. Hypertension, Diabetes Mellitus, and Insulin Resistance. 1997;7061:346–55.

Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. 2009;5(3):150–9.

Kansai T, Study H. Lower Serum Creatinine Is a New Risk Factor of Type 2 Diabetes. 2009;424–6.

Krentz AJ, Bailey CJ. Oral Antidiabetic Agents Current Role in Type 2 Diabetes Mellitus. 2005;65(3):385–411.

Diabetes VII, In C. CONTENTS DIAGNOSIS OF DIABETES. 2011;34.

Korytkowski M. When oral agents fail : practical barriers to starting insulin. 2002;18–24.

Review S. CLINICIAN ’ S CORNER Oral Antihyperglycemic Therapy for Type 2 Diabetes Scientific Review. 2002;287(3).

Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycaemia in type 2 diabetes: A patient-centered approach. Position statement of the american diabetes association (ADA) and the european association for the study of diabetes (EASD). Diabetologia. 2012;55(6):1577–96.

Statements P. Post Prandial Blood Glucose. 2001;24(4).

Published
2020-02-27
How to Cite
1.
Irene G, Kuswinarti K, Kusumawati M. Understanding Patients with Type 2 Diabetes Mellitus Using Oral Antidiabetic Drugs. JMH [Internet]. 27Feb.2020 [cited 31Mar.2020];2(5). Available from: https://journal.maranatha.edu/index.php/jmh/article/view/1110
Section
Articles